REDWOOD CITY, Calif., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has selected AT&T, Inc. as its preferred network partner for providing connectivity to the company’s medical devices.
AT&T, which is currently providing a pilot of the solution, will power Biotricity’s wearable medical devices with near real-time connectivity for data transmission which supports the company’s vision of creating a true Internet of Things (IoT) enabled wearable medical device. Connectivity will commence with the pending launch of Biotricity’s flagship product, the bioflux solution, which is expected to launch by year-end.
Biotricity founder and CEO Waqaas Al-Siddiq commented, “For medical device manufacturers to successfully enter and establish themselves in the new connected healthcare industry, it is imperative that they look beyond traditional forms of technological innovation. IoT, for example, would be an avenue for consideration and medical device manufacturers are uniquely positioned to be successful in this market, as they have a profound understanding of the regulatory process, critical applications, and patient risk. As we prepare to commercialize our first medical solution, we understand the importance of integrating IoT into next generation devices within the regulatory environment, as we believe there will be a true market advantage.”
“IoT will support a new generation of medical devices capable of transmitting data on an ongoing basis that help push care outside of the hospital and allow for continuous care virtually wherever the patients goes,” said Steve Burger, AVP of Business Development and Connected Health, AT&T IoT Solutions. “By wireless enabling their devices, Biotricity will help enable caregivers and healthcare institutions to use their patients’ data in near real-time to make informed and timely decisions.”
The Internet of Things (IoT) is penetrating all sectors of technology at an accelerating pace. IDC predicts the global market for the Internet of Things will nearly triple, reaching $1.7 trillion by 2020. This predicted increase is indicative of the importance IoT will have on innovation within the healthcare industry, and specifically medical devices which can provide relevant near real-time feedback to engage healthcare professionals in a timely manner. IoT connected devices will also allow medical device manufacturers to improve on preventative health care, remote patient home care and critical response care.
By enabling the medical community to perform deep data analytics and ultimately increase the efficiency and effectiveness of care, the utilization of IoT in medical devices will support key initiatives such as preventative care, home care, critical care response and others. In fact, as medical device manufacturers, healthcare practitioners, and enthusiasts continue to embrace the benefits of technology in healthcare, the intersection of medical technology and IoT will become increasingly more important.
About Biotricity Inc.
Biotricity is a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity’s R&D continues to focus on the preventative healthcare market, with a vision of putting health management into the hands of the individual. The company aims to support the self-management of critical and chronic conditions with the use of innovative solutions to ease the growing burden on the healthcare system. To learn more, visit www.biotricity.com.